These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1820731)

  • 1. Species differences in carcinogenicity: the role of metabolism and pharmacokinetics in risk assessment.
    Green T
    Ann Ist Super Sanita; 1991; 27(4):595-9. PubMed ID: 1820731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically-based pharmacokinetic models in risk and exposure assessment.
    Blancato JN
    Ann Ist Super Sanita; 1991; 27(4):601-8. PubMed ID: 1820732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in carcinogen metabolism and interspecies extrapolation.
    Dybing E; Huitfeldt HS
    IARC Sci Publ; 1992; (116):501-22. PubMed ID: 1428094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological considerations for combining carcinogenicity data for quantitative risk assessment.
    Vater ST; McGinnis PM; Schoeny RS; Velazquez SF
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):403-18. PubMed ID: 8128002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the risk of human cancer associated with exposure to methylene chloride.
    Reitz RH
    Ann Ist Super Sanita; 1991; 27(4):609-14. PubMed ID: 1820733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorinated aliphatic hydrocarbons used in the foods industry: the comparative pharmacokinetics of methylene chloride, 1,2 dichloroethane, chloroform and trichloroethylene after I.V. administration in the rat.
    Withey JR; Collins BT
    J Environ Pathol Toxicol; 1980; 3(5-6):313-32. PubMed ID: 7441087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic factors and their implication in the induction of mouse liver tumors by halogenated hydrocarbons.
    Bolt HM
    Arch Toxicol Suppl; 1987; 10():190-203. PubMed ID: 3555414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of chlorinated alkenes and alkanes as related to toxicity.
    Henschler D
    J Environ Pathol Toxicol; 1977; 1(2):125-33. PubMed ID: 553126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective detection and assessment of genotoxic hazards: a critical appreciation of the contribution of L. Ehrenberg.
    Wright AS; Bradshaw TK; Watson WP
    IARC Sci Publ; 1988; (89):237-48. PubMed ID: 3058596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in carcinogenicity: the role of metabolism in human risk evaluation.
    Green T
    Teratog Carcinog Mutagen; 1990; 10(2):103-13. PubMed ID: 1973849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments. The trichloroethylene example.
    Rudén C
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):80-94. PubMed ID: 11846638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health risk assessment.
    Abelson PH
    Regul Toxicol Pharmacol; 1993 Apr; 17(2 Pt 1):219-23. PubMed ID: 8484029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichloromethane.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():449-65. PubMed ID: 397173
    [No Abstract]   [Full Text] [Related]  

  • 19. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe.
    Van Oosterhout JP; Van der Laan JW; De Waal EJ; Olejniczak K; Hilgenfeld M; Schmidt V; Bass R
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):6-17. PubMed ID: 9056497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrutinizing ACGIH risk assessments: the trichloroethylene case.
    Rudén C
    Am J Ind Med; 2003 Aug; 44(2):207-13. PubMed ID: 12874854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.